Floatz logo

Prometrium

Hypoestrogenism

Johns Hopkins UniversityPhase 4 / ApprovedActive
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Hypoestrogenism cohort.

Asset / SponsorPhaseRating
17-beta-estradiol
Johns Hopkins University
Phase 4BB

Same molecule, other indications

Prometrium is also rated in:

polycystic ovary syndromeDormant
BB
Indicative ·
71 / 100
View asset →
Infertility, FemaleDormant
BB
Indicative ·
69 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →